USA flag logo/image

An Official Website of the United States Government

Waterless Dialysis System

Award Information

Agency:
Department of Defense
Branch:
Army
Award ID:
58145
Program Year/Program:
2003 / SBIR
Agency Tracking Number:
A012-1126
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
ASH ACCESS TECHNOLOGY, INC.
3601 SAGAMORE PARKWAY N STE B LAFAYETTE, IN 47904 5033
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2003
Title: Waterless Dialysis System
Agency / Branch: DOD / ARMY
Contract: DAMD17-02-C-0036
Award Amount: $730,000.00
 

Abstract:

Early and effective hemodialysis can decrease mortality of trauma patients with acute renal failure. Unfortunately, current technology is not easily deployed in the field or during transport of patients. The Sorbent Hemodialysis (SHD) System now beingdeveloped using technology from Ash Medical utilizes the SORB cartridge to produce and regenerate a small dialysate volume (6 liters). The SHD improvements over current technology that make it intrinsically safer and simpler are pressure-actuated bloodpumping, single- or dual-needle access, sorbent saturation monitor, and automated fluid management. The WDS makes further improvements by reducing total dialysate volume to about 2 liters, improving volumetric UF control, and adding variable bicarbonatebuffering. Ordinary potable water may be used for dialysate; it will be purified by the system before use. The equipment will be made more rugged and hazard resistant for military field applications. The user interface will be customized to therequirements of military healthcare personnel. In Phase 2, we will develop the concepts whose feasibility was demonstrated in Phase 1, to produce a prototype system that will be suitable for testing in a FDA-approved Investigational Device Exemption (IDE)clinical trial. Potential commercial applications include trauma victims in military and natural disaster situations. Waterless Dialysis System (WDS) innovations could improve SHD performance in home and acute dialysis. Incorporation of WDS features in SHDsystems may make the SHD useful during patient transport.

Principal Investigator:

Stephen Ash
Chairman, Director of R&D
7657424813
sash@hemocleanse.com

Business Contact:

Robert Truitt
President & CEO
7657424813
btruitt@hemocleanse.com
Small Business Information at Submission:

ASH MEDICAL SYSTEMS, INC.
3601 Sagamore Parkway North, Suite B Lafayette, IN 47904

EIN/Tax ID: 351571341
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No